Approval · Notice of Compliance 33469 · 2024
PMS-OXYCODONE: Notice of Compliance 33469
Issued June 14, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33469
- Date
- June 14, 2024
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Updates to the Product Monograph
- Canadian reference product
- OXY-IR (Purdue Pharma)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-OXYCODONE | Not yet assigned | — |
Medicinal ingredients
- OXYCODONE HYDROCHLORIDE 5 MG per TAB
- OXYCODONE HYDROCHLORIDE 10 MG per TAB
- OXYCODONE HYDROCHLORIDE 20 MG per TAB